Chlamydia screening for pregnant women aged 16–25 years attending an antenatal service: a cost‐effectiveness study-Reference-Cited by-同舟云学术

Chlamydia screening for pregnant women aged 16–25 years attending an antenatal service: a cost‐effectiveness study

Published:2015-08-26 Issue:7 Volume:123 Page:1194-1202
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG: Int J Obstet Gy

Author:

Ong JJ¹²,Chen M²³,Hocking J¹,Fairley CK²³,Carter R⁴,Bulfone L⁴,Hsueh A¹

Affiliation:

1. Melbourne School of Population and Global Health University of Melbourne Parkville Victoria Australia

2. Melbourne Sexual Health Centre Carlton Victoria Australia

3. Central Clinical School Monash University Clayton Victoria Australia

4. Deakin Health Economics Strategic Research Centre—Population Health Deakin University Burwood Victoria Australia

Funder

Australian Department of Health and Ageing Chlamydia Targeted Grants Programme

Publisher

Wiley

Subject

Obstetrics and Gynaecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.13567

Reference33 articles.

1. Surveillance systems reported in Communicable Diseases Intelligence.2014[www.health.gov.au/internet/main/publishings.nsf/Content/cda-surveil-surv_sys.htm]. Accessed 11 September 2014.

2. Health Protection Reports: latest infection reports. Public Health England. [www.gov.uk/government/collections/health-protection-report-latest-infection-reports]. Accessed 8 December 2014.

3. Screening pregnant women for chlamydia: what are the predictors of infection?

4. Chlamydia and associated factors in an under 20s antenatal population

5. Chlamydia trachomatis infection in pregnancy and effect of treatment on outcome

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of resistance-guided therapy for Mycoplasma genitalium in Australia;Scientific Reports;2024-06-04

2. Benefits and harms of antenatal and newborn screening programmes in health economic assessments: the VALENTIA systematic review and qualitative investigation;HEALTH TECHNOL ASSES;2024

3. Evaluation of Chlamydia trachomatis screening from the perspective of health economics: a systematic review;Frontiers in Public Health;2023-10-10

4. Cost-Effectiveness of Resistance Guided Therapy for Mycoplasma Genitalium for Women, Men Who Have Sex with Men (MSM) and Men Who Have Sex with Women (MSW) in Australia;2023

5. The association between adverse pregnancy outcomes with genital Chlamydia Trachomatis infection among pre-pregnancy couples in Shenzhen, China: A cross-sectional study;Frontiers in Public Health;2022-12-09